Kathleen M. Shields

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Effective therapies are needed to control excessive bleeding in a range of clinical conditions. We describe a surprisingly useful approach to improve hemostasis in vivo using a variant of coagulation factor Xa (FXa I16L). This conformationally pliant derivative is partially inactive due to a defect in transitioning from zymogen to protease 1,2. Using mouse(More)
  • 1